/
OPHLY
$4.83-$0.02 (-0.41%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.41 – $5.75
61% from low
Exchange
OTC Link
ADRC
Borrow rate
4.88%
Moderate
Price (6 mo)
Loading chart…
Change$-3.44
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $288.63B | $292.42B | $309.28B | $361.36B | $447.19B | $502.67B | $486.87B | $546.89B |
| Cost of revenue | $83.83B | $79.06B | $85.57B | $93.51B | $110.06B | $127.13B | $147.95B | $150.26B |
| Gross profit | $204.81B | $213.36B | $223.71B | $267.85B | $337.13B | $375.55B | $338.92B | $396.63B |
| Gross margin | 71.0% | 73.0% | 72.3% | 74.1% | 75.4% | 74.7% | 69.6% | 72.5% |
| R&D | $70.01B | $66.50B | $62.38B | $75.88B | $95.34B | $112.38B | $149.87B | $155.91B |
| Operating income | $62.01B | $77.49B | $98.33B | $103.19B | $141.96B | $163.10B | $59.75B | $109.57B |
| EBITDA | $74.20B | $91.92B | $116.85B | $123.62B | $161.90B | $178.44B | $91.54B | $149.60B |
| Net income | $51.54B | $59.70B | $75.42B | $80.52B | $112.72B | $127.98B | $50.05B | $73.97B |
| Net margin | 17.9% | 20.4% | 24.4% | 22.3% | 25.2% | 25.5% | 10.3% | 13.5% |
| EPS (diluted) | 11.14 | 13.16 | 50.36 | 54.05 | 76.92 | 88.87 | 35.47 | 52.73 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $462.9B | $50.58 | $49.02–$53.16 | 1 |
| 2028 | $453.1B | $44.25 | $42.88–$46.50 | 1 |
| 2029 | $471.0B | $49.08 | $47.56–$51.58 | 1 |
| 2030 | $492.4B | $52.53 | $50.90–$55.20 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$25.76
Price
$4.83
Implied upside
+433%
Peer comparison
ONO PHARM CO UNSP/ADR
ONO PHARM CO UNSP/ADR
Held by traders on TradeandTell
No one on the platform currently holds OPHLY.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in OPHLY as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2016-04-04 | 3-for-1 |
| 2014-05-29 | 5-for-1 |
Recent trades on TradeandTell
No one on the platform has traded OPHLY yet.